Modelling intravascular delivery from drug-eluting stents with biodurable coating: Investigation of anisotropic vascular drug diffusivity and arterial drug distribution

Computer Methods in Biomechanics and Biomedical Engineering

Volumn 17, Issue 3, 2014, Pages 187-198

  Zhu, Xiaoxiang ^a   Pack, Daniel W ^b   Braatz, Richard D ^a  

^a Massachusetts Institute of Technology   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

anisotropic diffusivity; arterial drug distribution; drug eluting stents; mathematical modelling; restenosis

Indexed keywords

ANALYTICAL EXPRESSIONS; ANISOTROPIC DIFFUSIVITY; DRUG DISTRIBUTION; DRUG-ELUTING STENTS; IN-STENT RESTENOSIS; RESTENOSIS; REVERSIBLE BINDING; THICKNESS DISTRIBUTIONS;

ANISOTROPY; ARTIFICIAL ORGANS; BLOOD VESSELS; COATINGS; DIFFUSION; DISEASES; FINITE VOLUME METHOD; MATHEMATICAL MODELS; PHARMACOKINETICS; STENTS;

LOADING;

ANISOTROPY; ARTERY WALL; ARTICLE; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG ELUTING STENT; DRUG RELEASE; INTRAVASCULAR DRUG ADMINISTRATION; MATHEMATICAL MODEL; PRIORITY JOURNAL; RESTENOSIS; SIMULATION;

ANISOTROPY; CORONARY VESSELS; DIFFUSION; DRUG-ELUTING STENTS; MODELS, BIOLOGICAL; PHARMACOKINETICS;

EID: 84891342035     PISSN: 10255842     EISSN: 14768259     Source Type: Journal    
DOI: 10.1080/10255842.2012.672815     Document Type: Article

References (43)

1. AcharyaG, ParkK. 2006. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev. 58(3):387-401.
2. BaileySR. 2009. DES design: theoretical advantages and disadvantages of stent strut materials, design, thickness, and surface characteristics. J Interv Cardiol. 22:S3-S17.
3. BalakrishnanB, DooleyJF, KopiaG, EdelmanER. 2007. Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution. J Control Release. 123(2):100-108.
4. BalakrishnanB, DooleyJ, KopiaG, EdelmanER. 2008. Thrombus causes fluctuations in arterial drug delivery from intravascular stents. J Control Release. 131(3):173-180.
5. BalakrishnanB, TzafririAR, SeifertP, GroothuisA, RogersC, EdelmanER. 2005. Strut position, blood flow, and drug deposition: implications for single and overlapping drug-eluting stents. Circulation. 111(22):2958-2965.
6. BorghiA, FoaE, BalossinoR, MigliavaccaF, DubiniG. 2008. Modelling drug elution from stents: effects of reversible binding in the vascular wall and degradable polymeric matrix. Comput Methods Biomech. 11(4):367-377.
7. CarlierSG, van DammeLCA, BlommerdeCP, WentzelJJ, van LangehoveG, VerheyeS, KockxMM, KnaapenMWM, ChengC, GijsenF et al., 2003. Augmentation of wall shear stress inhibits neointimal hyperplasia after stent implantation: inhibition through reduction of inflammation?Circulation. 107(21):2741-2746.
8. CohenDS, ErneuxT. 1998. Controlled drug release asymptotics. SIAM J Appl Math. 58(4):1193-1204.
9. CostaMA, SimonDI. 2005. Molecular basis of restenosis and drug-eluting stents. Circulation. 111(17):2257-2273.
10. CreelCJ, LovichMA, EdelmanER. 2000. Arterial paclitaxel distribution and deposition. Circ Res. 86(8):879-884.
11. DaemenJ, SerruysPW. 2007. Drug-eluting stent update 2007 part I: a survey of current and future generation drug-eluting stents: meaningful advances or more of the same?Circulation. 116(3):316-328.
12. DeconinckE, SohierI, De ScheerderI, Van Den MooterG. 2008. Pharmaceutical aspects of drug eluting stents. J Pharm Sci. 97(12):5047-5060.
13. DurranDR. 1999. Numerical methods for wave equations in geophysical fluid dynamics. New York: Springer.
14. FattoriR, PivaT. 2003. Drug-eluting stents in vascular intervention. Lancet. 361(9353):247-249.
15. FinkelsteinA, McCleanD, KarS, TakizawaK, VargheseK, BaekN, ParkK, FishbeinMC, MakkarR, LitvackF et al., 2003. Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation. 107(5):777-784.
16. GrassiM, PontrelliG, TeresiL, GrassiG, ComelL, FerlugaA, GalassoL. 2009. Novel design of drug delivery in stented arteries: a numerical comparative study. Math Biosci Eng. 6(3):493-508.
17. HossainyS, PrabhuS. 2008. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating. J Biomed Mater Res A. 87A(2):487-493.
18. HwangCW, EdelmanER. 2002. Arterial ultrastructure influences transport of locally delivered drugs. Circ Res. 90(7):826-832.
19. HwangCW, LevinAD, JonasM, LiPH, EdelmanER. 2005. Thrombosis modulates arterial drug distribution for drug-eluting stents. Circulation. 111(13):1619-1626.
20. HwangCW, WuD, EdelmanER. 2001. Physiological transport forces govern drug distribution for stent-based delivery. Circulation. 104(5):600-605.
21. KamathKR, BarryJJ, MillerKM. 2006. The Taxus (TM) drug-eluting stent: a new paradigm in controlled drug delivery. Adv Drug Deliv Rev. 58(3):412-436.
22. KolachalamaVB, TzafririAR, ArifinDY, EdelmanER. 2010. Luminal flow patterns dictate arterial drug deposition in stent-based delivery (vol 133, pg 24, 2009). J Control Release. 146(1):160.
23. LevinAD, VukmirovicN, HwangCW, EdelmanER. 2004. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci USA. 101(25):9463-9467.
24. LovichMA, CreelC, HongK, HwangCW, EdelmanER. 2001. Carrier proteins determine local pharmacokinetics and arterial distribution of paclitaxel. J Pharm Sci. 90(9):1324-1335.
25. LovichMA, EdelmanER. 1995. Mechanisms of transmural heparin transport in the rat abdominal-aorta after local vascular delivery. Circ Res. 77(6):1143-1150.
26. LovichMA, EdelmanER. 1996. Computational simulations of local vascular heparin deposition and distribution. Am J Physiol Heart C. 40(5):H2014-H2024.
27. LovichMA, PhilbrookM, SawyerS, WeselcouchE, EdelmanER. 1998. Arterial heparin deposition: role of diffusion, convection, and extravascular space. Am J Physiol Heart C. 44(6):H2236-H2242.
28. MongrainR, FaikI, LeaskRL, Rodes-CabauJ, LaroseE, BertrandOF. 2007. Effects of diffusion coefficients and struts apposition using numerical simulations for drug eluting coronary stents. J Biomech Eng-T ASME. 129(5):733-742.
29. MurataT, HiroT, FujiiT, YasumotoK, MurashigeA, KohnoM, YamadaJ, MiuraT, MatsuzakiM. 2002. Impact of the cross-sectional geometry of the post-deployment coronary stent on in-stent neointimal hyperplasia: an intravascular ultrasound study. Circ J. 66(5):489-493.
30. PontrelliG, de MonteF. 2010. A multi-layer porous wall model for coronary drug-eluting stents. Int J Heat Mass Transfer. 53(19-20):3629-3637.
31. RanadeSV, MillerKM, RichardRE, ChanAK, AllenMJ, HelmusMN. 2004. Physical characterization of controlled release of paclitaxel from the TAXUS(TM) Express(2TM) drug-eluting stent. J Biomed Mater Res A. 71A(4):625-634.
32. SakharovDV, KalachevLV, RijkenDC. 2002. Numerical simulation of local pharmacokinetics of a drug after intravascular delivery with an eluting stent. J Drug Target. 10(6):507-513.
33. SantinM, ColomboP, BruschiG. 2005. Interfacial biology of in-stent restenosis. Expert Rev Med Dev. 2(4):429-443.
34. SharkawiT, Leyni-BarbazD, ChikhN, McMullenJN. 2005. Evaluation of the in vitro drug release from resorbable biocompatible coatings for vascular stents. J Bioact Compat Pol. 20(2):153-168.
35. SousaJE, SerruysPW, CostaMA. 2003. New frontiers in cardiology: drug-eluting stents: part I. Circulation. 107(17):2274-2279.
36. TakebayashiH, MintzGS, CarlierSG, KobayashiY, FujiiK, YasudaT, CostaRA, MoussaI, DangasGD, MehranR et al., 2004. Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation. Circulation. 110(22):3430-3434.
37. TzafririAR, VukmirovicN, KolachalamaVB, AstafievaI, EdelmanER. 2010. Lesion complexity determines arterial drug distribution after local drug delivery. J Control Release. 142(3):332-338.
38. VairoG, CioffiM, CottoneR, DubiniG, MigliavaccaF. 2010. Drug release from coronary eluting stents: a multidomain approach. J Biomech. 43(8):1580-1589.
39. VenkatramanS, BoeyF. 2007. Release profiles in drug-eluting stents: issues and uncertainties. J Control Release. 120(3):149-160.
40. WentzelJJ, KramsR, SchuurbiersJCH, OomenJA, KloetJ, van der GiessenWJ, SerruysPW, SlagerCJ. 2001. Relationship between neointimal thickness and shear stress after wallstent implantation in human coronary arteries. Circulation. 103(13):1740-1745.
41. WesselyR, SchomigA, KastratiA. 2006. Sirolimus and paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol. 47(4):708-714.
42. ZhangFM, FathM, MarksR, LinhardtRJ. 2002. A highly stable covalent conjugated heparin biochip for heparin-protein interaction studies. Anal Biochem. 304(2):271-273.
43. ZuninoP, D'AngeloC, PetriniL, VergaraC, CapelliC, MigliavaccaF. 2009. Numerical simulation of drug eluting coronary stents: mechanics, fluid dynamics and drug release. Comput Methods Appl M. 198(45-46):3633-3644.